A detailed history of ETF Managers Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 1,734 shares of GILD stock, worth $158,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,734
Holding current value
$158,400
% of portfolio
0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$77.31 - $88.08 $134,055 - $152,730
1,734 New
1,734 $143,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $7,859 - $8,977
-132 Reduced 4.63%
2,718 $168,000
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $55,642 - $62,669
-964 Reduced 25.28%
2,850 $178,000
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $94,699 - $118,668
-1,635 Reduced 30.01%
3,814 $228,000
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $97,320 - $110,460
-1,500 Reduced 21.59%
5,449 $400,000
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $103,498 - $111,662
1,529 Added 28.21%
6,949 $493,000
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $19,485 - $21,290
-307 Reduced 5.36%
5,420 $368,000
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $26,040 - $29,711
-434 Reduced 7.04%
5,727 $375,000
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $942,599 - $1.07 Million
-16,639 Reduced 72.98%
6,161 $349,000
Q3 2020

Nov 16, 2020

SELL
$62.1 - $78.08 $313,294 - $393,913
-5,045 Reduced 18.12%
22,800 $1.42 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $1.15 Million - $1.33 Million
15,856 Added 132.25%
27,845 $2.08 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $750,871 - $961,757
11,989 New
11,989 $910,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.